{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:20:22Z","timestamp":1791566422528,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["848223"],"award-info":[{"award-number":["848223"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010571","name":"BMBF Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["2018\\u2013394455587"],"award-info":[{"award-number":["2018\\u2013394455587"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-TRR 179\/2"],"award-info":[{"award-number":["SFB-TRR 179\/2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["272983813"],"award-info":[{"award-number":["272983813"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jhepr.2023.100997","type":"journal-article","created":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T19:21:19Z","timestamp":1703964079000},"page":"100997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine component"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8853-3834","authenticated-orcid":false,"given":"Jinpeng","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Harati Taji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6352-1415","authenticated-orcid":false,"given":"Anna D.","family":"Kosinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edanur","family":"Ates Oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlo","family":"Bielytskyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Shein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6761-0583","authenticated-orcid":false,"given":"Shohreh","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-5433","authenticated-orcid":false,"given":"Katja","family":"Steiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-1911","authenticated-orcid":false,"given":"Ulrike","family":"Protzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K.","family":"Sch\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100997_bib1","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1586\/erv.09.121","article-title":"Use of hepadnavirus core proteins as vaccine platforms","volume":"8","author":"Whitacre","year":"2009","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.jhepr.2023.100997_bib2","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1038\/sj.emboj.7601841","article-title":"Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions","volume":"26","author":"Seitz","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.jhepr.2023.100997_bib3","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1126\/science.3491425","article-title":"The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen","volume":"234","author":"Milich","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.jhepr.2023.100997_bib4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4049\/jimmunol.139.4.1223","article-title":"Immune response to hepatitis B virus core antigen (HBcoreAg): localization of T cell recognition sites within HBcoreAg\/HBeAg","volume":"139","author":"Milich","year":"1987","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2023.100997_bib5","doi-asserted-by":"crossref","first-page":"14648","DOI":"10.1073\/pnas.94.26.14648","article-title":"Role of B cells in antigen presentation of the hepatitis B core","volume":"94","author":"Milich","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2023.100997_bib6","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1128\/JVI.00586-10","article-title":"Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity","volume":"84","author":"Porterfield","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jhepr.2023.100997_bib7","article-title":"Cationic domains in particle-forming and assembly-deficient HBV core antigens capture mammalian RNA that stimulates Th1-biased antibody responses by DNA vaccination","volume":"8","author":"Krieger","year":"2018","journal-title":"Scientific Rep"},{"key":"10.1016\/j.jhepr.2023.100997_bib8","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.4049\/jimmunol.168.10.4951","article-title":"Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain","volume":"168","author":"Riedl","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jhepr.2023.100997_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075938","article-title":"A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1\/Th2 switch in the immune responses of mice","volume":"8","author":"Sominskaya","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2023.100997_bib10","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbrc.2004.12.118","article-title":"Recombinant viral capsids as an efficient vehicle of oligonucleotide delivery into cells","volume":"327","author":"Cooper","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhepr.2023.100997_bib11","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.4049\/jimmunol.172.3.1777","article-title":"Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects","volume":"172","author":"Storni","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jhepr.2023.100997_bib12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2023.100997_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.jhepr.2023.100997_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000373","article-title":"Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques","volume":"5","author":"Stahl-Hennig","year":"2009","journal-title":"Plos Pathog"},{"key":"10.1016\/j.jhepr.2023.100997_bib15","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.4049\/jimmunol.168.12.6099","article-title":"Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity","volume":"168","author":"Stern","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2023.100997_bib16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2022.12.013","article-title":"Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models","volume":"78","author":"Su","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100997_bib17","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMra1810477","article-title":"Global elimination of chronic hepatitis","volume":"380","author":"Thomas","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100997_bib18","unstructured":"WHO. Hepatitis B Fact Sheet. 2022 2022 [cited; Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"10.1016\/j.jhepr.2023.100997_bib19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/hep.28280","article-title":"Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta-analysis","volume":"63","author":"Lok","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100997_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.gastro.2018.10.032","article-title":"Targeting innate and adaptive immune responses to cure chronic HBV infection","volume":"156","author":"Gehring","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100997_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5005\/jp-journals-10018-1109","article-title":"Immunotherapy for chronic hepatitis B using HBsAg-based vaccine formulations: from preventive commercial vaccines to therapeutic approach julio cesar aguilar","volume":"4","author":"Aguilar","year":"2014","journal-title":"Euroasian J Hepato-Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100997_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1586\/14760584.5.5.707","article-title":"Therapeutic vaccination in chronic hepatitis B virus carriers","volume":"5","author":"Pol","year":"2006","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.jhepr.2023.100997_bib23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.vaccine.2015.12.060","article-title":"Protein-prime\/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice","volume":"34","author":"Backes","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2023.100997_bib24","article-title":"Immunogenicity and antiviral response of therapeutic hepatitis B vaccination in a mouse model of HBeAg-negative, persistent HBV infection","volume":"vol. 9","author":"Kosinska","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jhepr.2023.100997_bib25","doi-asserted-by":"crossref","first-page":"100603","DOI":"10.1016\/j.jhepr.2022.100603","article-title":"Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance","volume":"5","author":"Sacherl","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100997_bib26","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2020.01.032","article-title":"Knockdown of virus antigen expression increases therapeutic vaccine efficacy in high-titer hepatitis B virus carrier mice","volume":"158","author":"Michler","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100997_bib27","doi-asserted-by":"crossref","first-page":"8536","DOI":"10.1021\/jacs.1c12439","article-title":"Transient RNA interactions leave a covalent imprint on a viral capsid protein","volume":"144","author":"Harati Taji","year":"2022","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jhepr.2023.100997_bib28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10858-011-9569-2","article-title":"A software framework for analysing solid-state MAS NMR data","volume":"51","author":"Stevens","year":"2011","journal-title":"J Biomol NMR"},{"key":"10.1016\/j.jhepr.2023.100997_bib29","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1128\/JVI.03134-12","article-title":"Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules","volume":"87","author":"Dion","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jhepr.2023.100997_bib30","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ymthe.2019.02.001","article-title":"Evaluation of a fully human, hepatitis B virus-specific chimeric antigen receptor in an immunocompetent mouse model","volume":"27","author":"Festag","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.jhepr.2023.100997_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47149-w","article-title":"Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection","volume":"9","author":"Kosinska","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2023.100997_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0021-9258(19)52465-6","article-title":"The ultraviolet absorption spectra of proteins","volume":"193","author":"Goldfarb","year":"1951","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2023.100997_bib33","series-title":"WHO\/Paul-Ehrlich-Institut informal consultation on scientific and regulatory considerations on the stability evaluation of vaccines under controlled temperature chain","author":"WHO","year":"2013"},{"key":"10.1016\/j.jhepr.2023.100997_bib34","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1073\/pnas.0711976105","article-title":"The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine","volume":"105","author":"Trumpfheller","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2023.100997_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.virol.2010.08.015","article-title":"A\u00a0simple and general method for determining the protein and nucleic acid content of viruses by UV absorbance","volume":"407","author":"Porterfield","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.jhepr.2023.100997_bib36","series-title":"Cold Spring Harbor symposia on quantitative biology","first-page":"1","article-title":"Approaching the asymptote? Evolution and revolution in immunology","author":"Janeway","year":"1989"},{"key":"10.1016\/j.jhepr.2023.100997_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41541-019-0132-6","article-title":"The how\u2019s and what\u2019s of vaccine reactogenicity","volume":"4","author":"Herv\u00e9","year":"2019","journal-title":"npj Vaccin"},{"key":"10.1016\/j.jhepr.2023.100997_bib38","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A\u00a0Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2023.100997_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature04734","article-title":"Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses","volume":"441","author":"Kato","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2023.100997_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2023.100997_bib41","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40264-015-0350-4","article-title":"Comparative safety of vaccine adjuvants: a summary of current evidence and future needs","volume":"38","author":"Petrovsky","year":"2015","journal-title":"Drug Saf"},{"key":"10.1016\/j.jhepr.2023.100997_bib42","first-page":"2013","article-title":"Activation of dendritic cells by the novel Toll-like receptor 3 agonist RGC100","author":"Naumann","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jhepr.2023.100997_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2004.02.022","article-title":"Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides","volume":"97","author":"Mutwiri","year":"2004","journal-title":"J controlled release"},{"key":"10.1016\/j.jhepr.2023.100997_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00141-18","article-title":"Intrastructural help: harnessing T helper cells induced by licensed vaccines for improvement of HIV env antibody responses to virus-like particle vaccines","volume":"92","author":"Elsayed","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.jhepr.2023.100997_bib45","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4049\/jimmunol.147.2.410","article-title":"Role of intrastructural\/intermolecular help in immunization with peptide-phospholipid complexes","volume":"147","author":"Goodman-Snitkoff","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.jhepr.2023.100997_bib46","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/329547a0","article-title":"Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site","volume":"329","author":"Milich","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2023.100997_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002919","article-title":"Structural organization of pregenomic RNA and the carboxy-terminal domain of the capsid protein of hepatitis B virus","volume":"8","author":"Wang","year":"2012","journal-title":"Plos Pathog"},{"key":"10.1016\/j.jhepr.2023.100997_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005802","article-title":"Importin beta can bind hepatitis B virus core protein and empty core-like particles and induce structural changes","volume":"12","author":"Chen","year":"2016","journal-title":"Plos Pathog"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923003282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923003282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:07:32Z","timestamp":1778904452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923003282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2589555923003282"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100997","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine component","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100997"}}